Benjamin R. Clopper

Early Estimate of Nirsevimab Effectiveness for Prevention of Respiratory Syncytial Virus–Associated Hospitalization Among Infants Entering Their First Respiratory Syncytial Virus Season — New Vaccine Surveillance Network, October 2023–February 2024

R. Link-Gelles, F. Dawood, R. Selvarangan, 2024, MMWR. Morbidity and mortality weekly report.

Respiratory Virus Surveillance Among Children with Acute Respiratory Illnesses — New Vaccine Surveillance Network, United States, 2016–2021

Mary D. Moffatt, A. Curns, M. McMorrow, 2022, MMWR. Morbidity and mortality weekly report.